NDC 70261-518

Brim-Dor PF

Brimonidine - Dorzolamide Pf

Brim-Dor PF is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimisrx Nj. The primary component is Brimonidine Tartrate; Dorzolamide Hydrochloride.

• Product ID: 70261-518_6bb58e03-7db4-23a2-e053-2a91aa0a8800
• NDC: 70261-518
• Product Type: Human Prescription Drug
• Proprietary Name: Brim-Dor PF
• Generic Name: Brimonidine - Dorzolamide Pf
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2018-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: ImprimisRx NJ
• Substance Name: BRIMONIDINE TARTRATE; DORZOLAMIDE HYDROCHLORIDE
• Active Ingredient Strength: 2 mg/mL; mg/mL
• Pharm Classes: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 70261-518-10

10 mL in 1 BOTTLE, DROPPER (70261-518-10)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70261-518-10 [70261051810]

Brim-Dor PF SOLUTION/ DROPS

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
BRIMONIDINE TARTRATE	1.5 mg/mL

OpenFDA Data

• SPL SET ID: 6bb58e03-7db3-23a2-e053-2a91aa0a8800
• Manufacturer:
  • ImprimisRx NJ
• UNII:
  • 4S9CL2DY2H
  • QZO5366EW7

Pharmacological Class

• Adrenergic alpha-Agonists [MoA]
• alpha-Adrenergic Agonist [EPC]
• Carbonic Anhydrase Inhibitor [EPC]
• Carbonic Anhydrase Inhibitors [MoA]